Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-09-14 4:45 pm Purchase |
2020-09-03 | 13G | OBSEVA SA COM OBSVF |
ARMISTICE CAPITAL LLC | 5,053,322 8.500% |
5,053,322 (New Position) |
Filing History |
| 2020-09-11 4:45 pm Purchase |
2020-09-01 | 13G | PainReform Ltd. PRFX |
ARMISTICE CAPITAL LLC | 2,754 7.400% |
2,754 (New Position) |
Filing History |
| 2020-09-10 4:38 pm Purchase |
2020-08-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
ARMISTICE CAPITAL LLC | 756,000 5.600% |
756,000 (New Position) |
Filing History |
| 2020-09-08 5:15 pm Purchase |
2020-08-28 | 13G | SUN BIOPHARMA INC SNBP |
ARMISTICE CAPITAL LLC | 497,029 4.990% |
497,029 (New Position) |
Filing History |
| 2020-09-08 4:53 pm Purchase |
2020-08-28 | 13G | Motus GI Holdings, Inc. MOTS |
ARMISTICE CAPITAL LLC | 10,302 9.600% |
10,302 (New Position) |
Filing History |
| 2020-09-08 4:35 pm Purchase |
2020-08-26 | 13G | CohBar, Inc. CWBR |
ARMISTICE CAPITAL LLC | 81,875 4.100% |
81,875 (New Position) |
Filing History |
| 2020-09-08 4:29 pm Purchase |
2020-08-27 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
ARMISTICE CAPITAL LLC | 3,510,981 9.900% |
3,510,981 (New Position) |
Filing History |
| 2020-09-04 4:22 pm Unchanged |
2020-08-25 | 13G | NanoVibronix, Inc. NAOV |
ARMISTICE CAPITAL LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2020-08-31 5:09 pm Purchase |
2020-08-27 | 13G | CYCLO THERAPEUTICS INC CTDH |
ARMISTICE CAPITAL LLC | 28,861,787 16.000% |
16,811,787 (+139.52%) |
Filing History |
| 2020-08-20 5:10 pm Purchase |
2020-08-10 | 13G | Neovasc Inc. NVCN |
ARMISTICE CAPITAL LLC | 46,525 4.990% |
12,992 (+38.74%) |
Filing History |
| 2020-08-20 4:50 pm Purchase |
2020-08-13 | 13D | ReShape Lifesciences Inc. RSLS |
ARMISTICE CAPITAL LLC | 54 97.700% |
0 (+0.12%) |
Filing History |
| 2020-08-10 5:02 pm Purchase |
2020-07-31 | 13G | REXAHN PHARMACEUTICALS INC REXN |
ARMISTICE CAPITAL LLC | 44,145 1.000% |
44,145 (New Position) |
Filing History |
| 2020-08-10 4:55 pm Purchase |
2020-07-30 | 13G | Spectrum Pharmaceuticals, Inc. SPPI |
ARMISTICE CAPITAL LLC | 7,858,000 5.800% |
6,866,990 (+692.93%) |
Filing History |
| 2020-08-10 4:45 pm Purchase |
2020-07-30 | 13G | Ra Medical Systems, Inc. RMED |
ARMISTICE CAPITAL LLC | 3,045 4.990% |
1,548 (+103.46%) |
Filing History |
| 2020-08-10 4:42 pm Purchase |
2020-07-31 | 13G | EMERALD BIOSCIENCE INC EMBI |
ARMISTICE CAPITAL LLC | 15,187,057 6.300% |
15,187,057 (New Position) |
Filing History |